Unveiling the Secrets of Extreme Longevity: A Journey into Brazil's Supercentenarians
Imagine a world where people live well beyond their 100th birthday, and not just a few, but an entire community of them! This is the intriguing reality we're delving into today, as we explore the fascinating lives of Brazilian supercentenarians and their remarkable resilience.
In 2020, three Brazilian supercentenarians, aged 110 and above, survived COVID-19, a remarkable feat considering the pandemic's global impact. Their antibody responses were exceptional, suggesting an incredible immune system resilience, even at such advanced ages.
But here's where it gets even more fascinating: Brazil is home to three of the world's 10 oldest living men, and its diverse population holds over 8 million unique genomic variants, including rare protective genes that are often overlooked in more homogeneous populations.
Supercentenarians, it seems, have a unique immune system. They possess "killer" CD4+ T cells, which are virtually absent in younger individuals, and yet, they maintain cellular cleanup systems, known as proteasomes and autophagy, at levels comparable to much younger people.
One remarkable family in Brazil includes a 109-year-old woman with three nieces aged 100, 104, and 106, reinforcing the idea that siblings of centenarians are significantly more likely to reach extreme old age themselves.
Brazil's unique genetic diversity, shaped by its history of Portuguese colonization, African enslavement, European immigration, and the Japanese diaspora, has created a population with an incredible array of genetic variations.
A recent study identified over 8 million undescribed genomic variants in Brazilians, with some potentially harmful. This diversity could be the key to understanding the protective factors that allow supercentenarians to live such long and healthy lives.
The University of São Paulo's Human Genome and Stem Cell Research Center has embarked on a nationwide study, assembling a cohort of over 100 centenarians, including 20 supercentenarians, from various regions and backgrounds. The study aims to unravel the secrets of aging and disease resistance.
The cohort includes three supercentenarians who survived COVID-19 pre-vaccination, showcasing strong antibody levels and plasma proteins related to innate immune response. Some participants remain lucid and independent, a testament to their remarkable health.
One of the most intriguing findings is the immune system's adaptation for longevity. Supercentenarians' immune cells retain their cleanup ability, efficiently breaking down damaged proteins, akin to a well-oiled trash disposal system.
Scientists have discovered an unusual type of immune cell, CD4+ T cells, which act as attack cells in supercentenarians, a role typically reserved for other cell types. This transformation is virtually unseen in younger individuals.
Supercentenarians also have an abundance of natural killer cells, the body's first line of defense, which likely helps them combat chronic infections that would exhaust most immune systems.
A person who lived to 112, designated M116, revealed rare genetic variations that control the immune system. These variations seem to reduce inflammatory and autoimmune issues with age, offering a potential explanation for their exceptional longevity.
Beyond immune genes, the M116 genome revealed rare variations in genes responsible for cellular maintenance. Some genes aid in autophagy, the cell's recycling program, breaking down damaged proteins and reusing their components. Other rare gene variants ensure efficient mitochondrial function, the cell's power plants, converting food into energy.
Additionally, variants affect gene regulation and DNA repair, creating a robust maintenance system that keeps cells functioning smoothly for extended periods.
In older Brazilians, researchers identified over 2,000 unique genetic elements, 5 million DNA letters, and 140 immune system variations not found in global genetic databases. These adaptations may hold the key to understanding extreme old age.
Supercentenarians don't merely live longer by chance; their bodies resist typical aging processes. Instead of succumbing to heart disease, cancer, or dementia at normal ages, they delay or avoid these conditions through a combination of protective genes and environmental factors.
Understanding their maintenance systems could revolutionize aging research, offering strategies to promote healthy aging for all.
However, it's important to note that many claims of extreme longevity in Brazil lack official documentation. International organizations are working to validate these cases through various civil records.
This study was supported by the São Paulo Research Foundation and the National Council for Scientific and Technological Development. The authors declared no conflicts of interest, and the funders had no involvement in the study's design or decisions.
The study was published in Genomic Psychiatry on January 6, 2026, and approved by the Committee for Ethics in Research of the Institute of Biosciences at the University of São Paulo.
And this is the part most people miss: the potential for controversy. Could these findings spark differing opinions on aging and healthcare? What do you think? We'd love to hear your thoughts in the comments!
